{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T19:54:56Z","timestamp":1772999696212,"version":"3.50.1"},"update-to":[{"DOI":"10.1016\/j.biopha.2018.05.021","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000}}],"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.biopha.2018.05.021","type":"journal-article","created":{"date-parts":[[2018,5,15]],"date-time":"2018-05-15T09:17:20Z","timestamp":1526375840000},"page":"158-164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["RETRACTED: Tanshinone IIA ameliorates lipopolysaccharide-induced inflammatory response in bronchial epithelium cell line BEAS-2B by down-regulating miR-27a"],"prefix":"10.1016","volume":"104","author":[{"given":"Xiuxia","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.biopha.2018.05.021_bib0005","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.diii.2012.04.021","article-title":"Lung infections: the radiologist\u2019s perspective","volume":"93","author":"Beigelman-Aubry","year":"2012","journal-title":"Diagn. Intervent. Imaging"},{"issue":"3","key":"10.1016\/j.biopha.2018.05.021_bib0010","first-page":"175","article-title":"Clinical analysis of immune function changes in children with bronchial pneumonia","volume":"15","author":"Zhu","year":"2013","journal-title":"Zhongguo dang dai er ke za zhi = Chin. J. Contemp. Pediatr."},{"issue":"4 Suppl","key":"10.1016\/j.biopha.2018.05.021_bib0015","first-page":"1477","article-title":"Oxygen-driving and atomized mucosolvan inhalation combined with holistic nursing in the treatment of children severe bronchial pneumonia","volume":"28","author":"Yang","year":"2015","journal-title":"Pak. J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2018.05.021_bib0020","doi-asserted-by":"crossref","first-page":"488","DOI":"10.5114\/ceji.2014.47734","article-title":"Cellular immunity profile in children with congenital heart disease and bronchopneumonia: evaluation of lymphocyte subsets and regulatory T cells","volume":"39","author":"Huang","year":"2014","journal-title":"Cent. Eur. J. Immunol."},{"issue":"13","key":"10.1016\/j.biopha.2018.05.021_bib0025","first-page":"1","article-title":"Influence of external application of Chinese medicine combined with massage on pneumonia infants","volume":"10","author":"Kui-Hua","year":"2013","journal-title":"Nurs. Pract. Res."},{"issue":"1","key":"10.1016\/j.biopha.2018.05.021_bib0030","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jep.2012.12.013","article-title":"Naturally derived anti-inflammatory compounds from Chinese medicinal plants","volume":"146","author":"Wang","year":"2013","journal-title":"J. Ethnopharmacol."},{"issue":"12","key":"10.1016\/j.biopha.2018.05.021_bib0035","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1177\/0091270005282630","article-title":"Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use","volume":"45","author":"Zhou","year":"2005","journal-title":"J. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2018.05.021_bib0040","first-page":"231","article-title":"Tanshinone IIA induces apoptosis in human lung cancer A549 cells through the induction of reactive oxygen species and decreasing the mitochondrial membrane potential","volume":"25","author":"Chiu","year":"2010","journal-title":"Int. J. Mol. Med."},{"issue":"6","key":"10.1016\/j.biopha.2018.05.021_bib0045","doi-asserted-by":"crossref","first-page":"773","DOI":"10.3892\/ijmm_00000291","article-title":"Experimental study of the anti-cancer mechanism of Tanshinone IIA against human breast cancer","volume":"24","author":"Lu","year":"2009","journal-title":"Int. J. Mol. Med."},{"issue":"3","key":"10.1016\/j.biopha.2018.05.021_bib0050","first-page":"781","article-title":"Tanshinone IIA acts via p38 MAPK to induce apoptosis and the down-regulation of ERCC1 and lung-resistance protein in cisplatin-resistant ovarian cancer cells","volume":"25","author":"Jiao","year":"2011","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.biopha.2018.05.021_bib0055","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.biopha.2017.08.036","article-title":"Tanshinone IIA protects against chronic intermittent hypoxia-induced myocardial injury via activating the endothelin 1 pathway","volume":"95","author":"Wang","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2018.05.021_bib0060","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.ejphar.2016.09.041","article-title":"Tanshinone IIA inhibits myocardial remodeling induced by pressure overload via suppressing oxidative stress and inflammation: possible role of silent information regulator 1","volume":"791","author":"Feng","year":"2016","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2018.05.021_bib0065","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.bbrc.2010.07.037","article-title":"Tanshinone IIA improves impaired nerve functions in experimental diabetic rats","volume":"399","author":"Liu","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3\u20135","key":"10.1016\/j.biopha.2018.05.021_bib0070","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jsbmb.2009.01.011","article-title":"The anti-inflammatory activities of Tanshinone IIA, an active component of TCM, are mediated by estrogen receptor activation and inhibition of iNOS","volume":"113","author":"Fan","year":"2009","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"1","key":"10.1016\/j.biopha.2018.05.021_bib0075","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s10753-015-0259-1","article-title":"Anti-inflammatory activity of Tanshinone IIA in LPS-stimulated RAW264.7 macrophages via miRNAs and TLR4-NF-kappaB pathway","volume":"39","author":"Fan","year":"2016","journal-title":"Inflammation"},{"issue":"4","key":"10.1016\/j.biopha.2018.05.021_bib0080","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1164\/rccm.201506-1100OC","article-title":"Responses to bacteria, virus, and malaria distinguish the etiology of pediatric clinical pneumonia","volume":"193","author":"Valim","year":"2016","journal-title":"Am. J. Resp. Crit. Care Med."},{"issue":"10","key":"10.1016\/j.biopha.2018.05.021_bib0085","doi-asserted-by":"crossref","first-page":"L1041","DOI":"10.1152\/ajplung.00283.2015","article-title":"Influenza lung injury: mechanisms and therapeutic opportunities","volume":"309","author":"Gregory","year":"2015","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.biopha.2018.05.021_bib0090","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.clim.2016.12.008","article-title":"IL-17B is elevated in patients with pneumonia and mediates IL-8 production in bronchial epithelial cells","volume":"175","author":"Zhou","year":"2017","journal-title":"Clin. Immunol. (Orlando, Fla.)"},{"issue":"2","key":"10.1016\/j.biopha.2018.05.021_bib0095","doi-asserted-by":"crossref","first-page":"L133","DOI":"10.1152\/ajplung.00307.2015","article-title":"IL-27 enhances innate immunity of human pulmonary fibroblasts and epithelial cells through upregulation of TLR4 expression","volume":"310","author":"Su","year":"2016","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"29","key":"10.1016\/j.biopha.2018.05.021_bib0100","doi-asserted-by":"crossref","first-page":"5953","DOI":"10.1021\/acs.jafc.7b02109","article-title":"Intervention of dietary dipeptide gamma-l-glutamyl-l-valine (gamma-EV) ameliorates inflammatory response in a mouse model of LPS-induced sepsis","volume":"65","author":"Chee","year":"2017","journal-title":"J. Agric. Food Chem."},{"issue":"9","key":"10.1016\/j.biopha.2018.05.021_bib0105","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1248\/bpb.b16-00895","article-title":"Triterpenoids isolated from Alnus japonica inhibited LPS-induced inflammatory mediators in HT-29 cells and RAW264.7 cells","volume":"40","author":"Lee","year":"2017","journal-title":"Biol. Pharm. Bull."},{"issue":"3","key":"10.1016\/j.biopha.2018.05.021_bib0110","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1046\/j.1365-3083.2002.01137.x","article-title":"Differences in LPS-induced activation of bronchial epithelial cells (BEAS-2B) and type II-like pneumocytes (A-549)","volume":"56","author":"Schulz","year":"2002","journal-title":"Scand. J. Immunol."},{"issue":"6","key":"10.1016\/j.biopha.2018.05.021_bib0115","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/0891-5849(95)02211-2","article-title":"Effect of natural antioxidant tanshinone II-A on DNA damage by lipid peroxidation in liver cells","volume":"20","author":"Cao","year":"1996","journal-title":"Free Radic. Biol. Med."},{"issue":"1\u20133","key":"10.1016\/j.biopha.2018.05.021_bib0120","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ejphar.2009.02.003","article-title":"Tanshinone IIA reduces lethality and acute lung injury in LPS-treated mice by inhibition of PLA2 activity","volume":"607","author":"Xu","year":"2009","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.biopha.2018.05.021_bib0125","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1440-1681.2011.05498.x","article-title":"Tanshinone IIA suppresses lung injury and apoptosis, and modulates protein kinase B and extracellular signal-regulated protein kinase pathways in rats challenged with seawater exposure","volume":"38","author":"Li","year":"2011","journal-title":"Clin. Exp. Pharmacol. Phys."},{"issue":"1","key":"10.1016\/j.biopha.2018.05.021_bib0130","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jss.2015.02.062","article-title":"Tanshinone IIA ameliorates bleomycin-induced pulmonary fibrosis and inhibits transforming growth factor-beta-\u03b2-dependent epithelial to mesenchymal transition","volume":"197","author":"Tang","year":"2015","journal-title":"J. Surg. Res."},{"issue":"6","key":"10.1016\/j.biopha.2018.05.021_bib0135","doi-asserted-by":"crossref","first-page":"578","DOI":"10.7150\/ijms.8365","article-title":"Tanshinone IIA attenuates bleomycin-induced pulmonary fibrosis via modulating angiotensin-converting enzyme 2\/angiotensin-(1-7) axis in rats","volume":"11","author":"Wu","year":"2014","journal-title":"Int. J. Med. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2018.05.021_bib0140","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1582-4934.2008.00534.x","article-title":"Advances in microRNAs: implications for immunity and inflammatory diseases","volume":"13","author":"Sonkoly","year":"2009","journal-title":"J. Cell. Mol. Med."},{"issue":"1","key":"10.1016\/j.biopha.2018.05.021_bib0145","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12974-015-0246-3","article-title":"MiR-27a ameliorates inflammatory damage to the blood-spinal cord barrier after spinal cord ischemia: reperfusion injury in rats by downregulating TICAM-2 of the TLR4 signaling pathway","volume":"12","author":"Li","year":"2015","journal-title":"J. Neuroinflammation"},{"issue":"2","key":"10.1016\/j.biopha.2018.05.021_bib0150","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.cellimm.2014.06.006","article-title":"miR-27a is up regulated and promotes inflammatory response in sepsis","volume":"290","author":"Wang","year":"2014","journal-title":"Cell. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2018.05.021_bib0155","doi-asserted-by":"crossref","first-page":"327","DOI":"10.4049\/jimmunol.1400203","article-title":"miR-27a regulates inflammatory response of macrophages by targeting IL-10","volume":"193","author":"Xie","year":"2014","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2018.05.021_bib0160","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/FJC.0b013e3181671439","article-title":"Sodium Tanshinone IIA sulfonate protects cardiomyocytes against oxidative stress-mediated apoptosis through inhibiting JNK activation","volume":"51","author":"Yang","year":"2008","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2018.05.021_bib0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2006.04.044","article-title":"Tanshinone IIA inhibits LPS-induced NF-\u03baB activation in RAW 264.7 cells: possible involvement of the NIK\u2013IKK, ERK1\/2, p38 and JNK pathways","volume":"542","author":"Il Jang","year":"2006","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.biopha.2018.05.021_bib0170","doi-asserted-by":"crossref","first-page":"6495","DOI":"10.1007\/s11033-012-1477-3","article-title":"Tanshinone IIA protects PC12 cells from beta-amyloid(25-35)-induced apoptosis via PI3K\/Akt signaling pathway","volume":"39","author":"Dong","year":"2012","journal-title":"Mol. Biol. Rep."},{"issue":"12","key":"10.1016\/j.biopha.2018.05.021_bib0175","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1038\/aps.2010.176","article-title":"Tanshinone IIA attenuates angiotensin II-induced apoptosis via Akt pathway in neonatal rat cardiomyocytes","volume":"31","author":"Hong","year":"2010","journal-title":"Acta Pharmacol. Sin."},{"issue":"2","key":"10.1016\/j.biopha.2018.05.021_bib0180","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0955-0674(98)80143-9","article-title":"Signal transduction by the c-Jun N-terminal kinase (JNK)\u2014from inflammation to development","volume":"10","author":"Ip","year":"1998","journal-title":"Curr. Opin. Cell Biol."}],"updated-by":[{"DOI":"10.1016\/j.biopha.2022.112794","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T00:00:00Z","timestamp":1646956800000},"record-id":"36108"},{"DOI":"10.1016\/j.biopha.2022.112794","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000}},{"DOI":"10.1016\/j.biopha.2018.05.021","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000}}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217364430?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217364430?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T11:28:00Z","timestamp":1760095680000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332217364430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":36,"alternative-id":["S0753332217364430"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.05.021","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RETRACTED: Tanshinone IIA ameliorates lipopolysaccharide-induced inflammatory response in bronchial epithelium cell line BEAS-2B by down-regulating miR-27a","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.05.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}